COVID-19 epidemic spread worldwide. As of December 2022, more than 7.5% of the world's population has been infected, of which the number of deaths exceeds 1%, which seriously affects human health and social stability. Traditional Chinese medicine (TCM) had been implemented to prevent COVID-19 infection, including using herbal medicines, acupuncture, moxibustion, massage, Tai Chi, etc. However, the outcomes in trials of COVID-19 prevention with TCM were often inconsistent and irrelevant, making it difficult to draw conclusions when the evidence is synthesised. Thus, a standardised collection of outcomes is needed to aid the interpretation of study findings. The purpose of this study was to develop a core outcome set of COVID-19 prevention with TCM and identify the core outcomes that should be measured in relevant studies.
ContributorsJunhua Zhang1,2, Hongjie Zhao2,3, Bo Pang1,2, Keyi Wang1,2
1. Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
2. Chinese Clinical Trials Core Outcome Set Research Center, Tianjin 301617, China.
3. College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Disease Category: Infectious disease
Disease Name: Coronavirus
Age Range: 100
Sex: Either
Nature of Intervention: Traditional Chinese Medicine
- Clinical experts
- Conference participants
- Consumers (patients)
- Epidemiologists
- Ethicists
- Journal editors
- Methodologists
- Policy makers
- Researchers
- Statisticians
- COS for clinical trials or clinical research
- COS for practice
- Consensus conference
- Delphi process
- Interview
- Literature review
- Semi structured discussion
- Survey
- Systematic review
(1) Systematic literature review;(2)Qualitative semi-structured interview;(3)Two rounds of Delphi investigations;(4)Consensus conference